Peptidic lipopolysaccharide (LPS) antagonists are the subject of intensive research. We report
an NMR and modeling study of LBP-14 (RVQGRWKVRASFFK), a synthetic fragment of the
LPS binding protein (LBP). In a mixture with LPS we observed the transferred nuclear
Overhauser effect and determined the LPS-bound structure of LBP-14 that was used for docking
calculations to LPS. The derived complex was used to design a peptide that displayed more
than 50% increase in LPS inhibition in vitro.